281 related articles for article (PubMed ID: 25482553)
1. Phthalazin-1(2H)-one as a remarkable scaffold in drug discovery.
Vila N; Besada P; Costas T; Costas-Lago MC; Terán C
Eur J Med Chem; 2015 Jun; 97():462-82. PubMed ID: 25482553
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in the synthesis of phthalazin-1(2H)-one core as a relevant pharmacophore in medicinal chemistry.
Terán C; Besada P; Vila N; Costas-Lago MC
Eur J Med Chem; 2019 Jan; 161():468-478. PubMed ID: 30388463
[TBL] [Abstract][Full Text] [Related]
3. The chemistry and biological activity of heterocycle-fused quinolinone derivatives: A review.
Shiro T; Fukaya T; Tobe M
Eur J Med Chem; 2015 Jun; 97():397-408. PubMed ID: 25532473
[TBL] [Abstract][Full Text] [Related]
4. Phthalazinones 2: Optimisation and synthesis of novel potent inhibitors of poly(ADP-ribose)polymerase.
Cockcroft XL; Dillon KJ; Dixon L; Drzewiecki J; Kerrigan F; Loh VM; Martin NM; Menear KA; Smith GC
Bioorg Med Chem Lett; 2006 Feb; 16(4):1040-4. PubMed ID: 16290932
[TBL] [Abstract][Full Text] [Related]
5. Phthalazinone Scaffold: Emerging Tool in the Development of Target Based Novel Anticancer Agents.
Singh J; Suryan A; Kumar S; Sharma S
Anticancer Agents Med Chem; 2020; 20(18):2228-2245. PubMed ID: 32767957
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activity of structurally diverse phthalazine derivatives: A systematic review.
Sangshetti J; Pathan SK; Patil R; Akber Ansari S; Chhajed S; Arote R; Shinde DB
Bioorg Med Chem; 2019 Sep; 27(18):3979-3997. PubMed ID: 31401008
[TBL] [Abstract][Full Text] [Related]
7. Improvement of antibacterial activity of some sulfa drugs through linkage to certain phthalazin-1(2H)-one scaffolds.
Ibrahim HS; Eldehna WM; Abdel-Aziz HA; Elaasser MM; Abdel-Aziz MM
Eur J Med Chem; 2014 Oct; 85():480-6. PubMed ID: 25113876
[TBL] [Abstract][Full Text] [Related]
8. Heterocycle-thioacetic acid motif: a privileged molecular scaffold with potent, broad-ranging pharmacological activities.
Song Y; Zhan P; Liu X
Curr Pharm Des; 2013; 19(40):7141-54. PubMed ID: 23859548
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of some triazolophthalazine derivatives for their anti-inflammatory and antimicrobial activities.
Habib NS; Farghaly AM; Ashour FA; Bekhit AA; Abd El Razik HA; Abd El Azeim T
Arch Pharm (Weinheim); 2011 Aug; 344(8):530-42. PubMed ID: 21695712
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antimicrobial activity of 2-substituted [4-(1,3,4-oxadiazol-2-yl methyl)] phthalazin-1(2H)-one derivatives.
Sridhara AM; Reddy KR; Keshavayya J; Goud PS; Somashekar BC; Bose P; Peethambar SK; Gaddam SK
Eur J Med Chem; 2010 Nov; 45(11):4983-9. PubMed ID: 20813436
[TBL] [Abstract][Full Text] [Related]
11. Phthalazinones. Part 1: The design and synthesis of a novel series of potent inhibitors of poly(ADP-ribose)polymerase.
Loh VM; Cockcroft XL; Dillon KJ; Dixon L; Drzewiecki J; Eversley PJ; Gomez S; Hoare J; Kerrigan F; Matthews IT; Menear KA; Martin NM; Newton RF; Paul J; Smith GC; Vile J; Whittle AJ
Bioorg Med Chem Lett; 2005 May; 15(9):2235-8. PubMed ID: 15837300
[TBL] [Abstract][Full Text] [Related]
12. Bioactive heterocycles containing endocyclic N-hydroxy groups.
Rani R; Granchi C
Eur J Med Chem; 2015 Jun; 97():505-24. PubMed ID: 25466924
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationships of cis-tetrahydrophthalazinone/pyridazinone hybrids: a novel series of potent dual PDE3/PDE4 inhibitory agents.
Van der Mey M; Bommelé KM; Boss H; Hatzelmann A; Van Slingerland M; Sterk GJ; Timmerman H
J Med Chem; 2003 May; 46(10):2008-16. PubMed ID: 12723963
[TBL] [Abstract][Full Text] [Related]
14. New 4-(4-methyl-phenyl)phthalazin-1(2H)-one derivatives and their effects on alpha1-receptors.
Strappaghetti G; Brodi C; Giannaccini G; Betti L
Bioorg Med Chem Lett; 2006 May; 16(10):2575-9. PubMed ID: 16545955
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones.
Eldehna WM; Ibrahim HS; Abdel-Aziz HA; Farrag NN; Youssef MM
Eur J Med Chem; 2015 Jan; 89():549-60. PubMed ID: 25462265
[TBL] [Abstract][Full Text] [Related]
16. Some recent approaches of biologically active substituted pyridazine and phthalazine drugs.
Asif M
Curr Med Chem; 2012; 19(18):2984-91. PubMed ID: 22519394
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and pharmacological evaluation of N-(dimethylamino)ethyl derivatives of benzo- and pyridopyridazinones.
Pakulska W; Malinowski Z; Szczesniak AK; Czarnecka E; Epsztajn J
Arch Pharm (Weinheim); 2009 Jan; 342(1):41-7. PubMed ID: 19051195
[TBL] [Abstract][Full Text] [Related]
18. A review on antioxidant potential of bioactive heterocycle benzofuran: Natural and synthetic derivatives.
Chand K; Rajeshwari ; Hiremathad A; Singh M; Santos MA; Keri RS
Pharmacol Rep; 2017 Apr; 69(2):281-295. PubMed ID: 28171830
[TBL] [Abstract][Full Text] [Related]
19. The use of spirocyclic scaffolds in drug discovery.
Zheng Y; Tice CM; Singh SB
Bioorg Med Chem Lett; 2014 Aug; 24(16):3673-82. PubMed ID: 25052427
[TBL] [Abstract][Full Text] [Related]
20. Novel antiasthmatic agents with dual activities of thromboxane A2 synthetase inhibition and bronchodilation. 2. 4-(3-Pyridyl)-1(2H)-phthalazinones.
Yamaguchi M; Kamei K; Koga T; Akima M; Maruyama A; Kuroki T; Ohi N
J Med Chem; 1993 Dec; 36(25):4061-8. PubMed ID: 8258828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
